Medicover’s socially sustainable commercial paper listed on Nasdaq Stockholm

On 13 April 2023, Medicover launched a Socially Sustainable Commercial Paper Programme under its Social Finance Framework. On 18 April 2023, the commercial paper will be admitted to trading on Nasdaq Stockholm, segment STO Sustainable Commercial Paper.

“Social sustainability composes the core of how we operate and invest in healthcare and health. Through the launch and listing of our socially sustainable commercial paper, we are broadening our financing in a way that reflects our business and will be important as we continue to work for better health in the markets we operate”, says Fredrik Rågmark, CEO of Medicover.

As of 17 April 2023, Medicover had issued socially sustainable commercial papers for SEK 120 million under its Socially Sustainable Commercial Paper Programme with a framework amount of SEK 2 billion, or the corresponding amount in EUR. Nordea and SEB have acted as issuing agents in connection with the issues.

More information about the programme and Medicover's Social Finance Framework can be found at www.medicover.com.

For further information, please contact:

Hanna Bjellquist, Head of Investor Relations

+46 703 033 272
hanna.bjellquist@medicover.com

Medicover is a leading international healthcare and diagnostic services company and was founded in 1995. Medicover operates a large number of ambulatory clinics, hospitals, specialty-care facilities, laboratories and blood-drawing points and the largest markets are Poland, Germany, Romania and India. In 2022, Medicover had revenue of €1,510 million and more than 44,000 employees. For more information, go to www.medicover.com